• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    MPO's 2023 Medical Device Industry Year in Review

    The Beat Goes On in the Cardiovascular Device Market

    Medical Manufacturers Gain Support from 3D Printing

    The Intelligent Tools Medical Device Manufacturers Already Own

    MPO's 2023 Medtech Supply Chain Survey
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    MPO's Most-Read Stories This Week—Dec. 9

    Babson Diagnostics’ BetterWay Achieves Regulatory Milestone

    WhiteSwell Successfully Treats Acute Decompensated Heart Failure in Study

    Everly Health Releases At-Home Collection Kidney Health Test

    Kenco Adds Two to its Life Sciences Division Team
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    MPO's 2023 Medical Device Industry Year in Review

    The Beat Goes On in the Cardiovascular Device Market

    Medical Manufacturers Gain Support from 3D Printing

    The Intelligent Tools Medical Device Manufacturers Already Own

    MPO's 2023 Medtech Supply Chain Survey
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    A Peek Into the 2028 MPO Summit

    Retail Healthcare Disruptors and Medical Devices

    Six Developments Your Talent Strategy Should Prepare for in 2024

    The Power and Paradox of Never

    Navigating the Q-Sub Program: How Experienced Lab Partners Can Help Streamline Regulatory Submission
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    BMP Medical

    Medbio LLC

    Braxton Manufacturing

    Cirtec Medical

    Providence Enterprise USA Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Telemedicine for Neurology: 5 Benefits of Remote Management

    Machining 101: A Review of Machining Components with a Five-Axis System

    MedTech 2024: Top 5 Trends Shaping a Dynamic Industry

    Early Warning: A Q&A with Abbott's CMO of Heart Failure

    2023 in Review: Medtech's Mega-M&A Is MIA
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    BMP Medical

    Medbio LLC

    Braxton Manufacturing

    Cirtec Medical

    Providence Enterprise USA Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Google’s Search for Direction in Healthcare

    ...

    Google’s Search for Direction in Healthcare
    Michael Barbella, Managing Editor03.07.19
    Fake news, begone: Reports of Alphabet’s healthcare struggles have not been greatly exaggerated.

    That bears repeating: Not been greatly exaggerated.

    Indeed, Google’s parent company is foundering a bit in its attempt to claim a significant stake in the industry, but its failures should not be mistaken for waning influence or interest in medicine. Truth be told, Alphabet’s healthcare roots are more extensive and entrenched than most people realize.

    “Google has always seen itself as more than a search and advertising company,” concludes a 47-page report from New York, N.Y.-based research firm CB Insights. “It’s...betting that its AI prowess can create a powerful new paradigm for the detection, diagnosis, and treatment of disease.”

    That bet is already beginning to pay off. For every stumble like Google Glass, Google Health, Google Helpouts, and the glucose-sensing Smart Lens (shelved last fall over scientific and biological challenges), there are triumphs such as Google Fit, Onduo, G Suite, and Verb Surgical.

    Scads more potential coups lurk in Alphabet’s pipeline, thanks to its bevy of healthcare-related acquisitions, venture capital investments, partnerships/collaborations, and patent filings. The company’s venture arm, GV (the former Google Ventures), has backed nearly 60 life sciences organizations over the last decade, including consumer-oriented brands like 23andMe, as well as data management entities (DNAnexus), and disease screening specialists (Denali Therapeutics, Freenome). The latter company likely won Alphabet funding by appealing to the larger firm’s commitment to improve early disease detection (particularly cancer). Freenome is developing technology to detect cancer in its early stages by pinpointing trace amounts of DNA that tumors shed into the bloodstream (circulating tumor DNA).

    Similarly, the 2017 purchase of Seattle startup Senosis Health could help Alphabet improve anemia and chronic obstructive pulmonary disease detection. Apps developed by Senosis turned smartphones into simple monitoring devices that could collect health metrics to diagnose pulmonary function, hemoglobin levels, and other critical health information.

    One of Alphabet’s most important healthcare-related acquisitions, however, arguably was its 2014 purchase of British artificial intelligence firm DeepMind, a startup whose AlphaGo algorithm beat the world champion of the abstract strategy board game Go in 2016. Last fall, Alphabet absorbed DeepMind’s health division, which is developing tools to scrub EHR data for better, faster health services. DeepMind’s AI prowess is likely to play a key role in helping Alphabet employ artificial intelligence techniques to solve fundamental problems in science and human biology.

    “Over the coming years, we expect AI to help scientists make transformative advances on problems ranging from protein folding to image analysis, potentially improving medical diagnosis, drug discovery, and much more,” DeepMind’s founders wrote in a November 2018 blog post. “We’re excited to play our part in that journey both at DeepMind and at Google, in the service of patients and clinicians around the world.”

    Although the world of machine learning and AI is still in its infancy, Alphabet is already leveraging the technology to help pathologists spot cancer cells in tumor biopsies, and interpret retinal scans to faster diagnose diabetic retinopathy. Moreover, DeepMind has created an algorithm that can predict the complex, three-dimensional shapes into which proteins can be folded—a key step in understanding biological processes and finding the molecules necessary for developing new medicines.

    DeepMind also is working with Moorfields Eye Hospital in London to improve eye care, developing an AI system that can match leading experts in diagnosing various optical conditions, and recommend the correct referral decision for more than 50 eye diseases with 94 percent accuracy. In addition, DeepMind has partnered with both the National Health Service and Cancer Research UK Centre at Imperial College (London) to improve upon tumor identification research. Alphabet’s previous research in this area yielded algorithms that could detect metastasized breast cancer tumors with a 92 percent accuracy rate.

    To coordinate its plethora of digital health initiatives, Google last fall established a new healthcare unit that includes a team that previously operated under DeepMind. The company tapped healthcare veteran David Feinberg, CEO of Geisinger Health System, to head the new unit.

    Google Health will primarily be focused on creating digital products and services that can be sold to doctors and hospitals—an approach that could help differentiate the search giant from other medtech industry outsiders looking to move into the space (Amazon, Apple). And while the diversity of healthcare initiatives in Google’s crosshairs are promising for the future of medicine, the disparity could ultimately undermine the company’s ability to deliver on many of its innovations, CB Insights warns.

    “Google is working on so many initiatives focused on so many different facets of healthcare across so many areas of the company that the chances of failure are high,” the CB Insights report states. “But so is the potential for success. Ultimately, if Google can find effective solutions for any one of the many issues it’s tackling, there’s a potential to apply lessons and successful approaches elsewhere, and create a new data- and AI-driven healthcare paradigm.” 
    Related Searches
    • artificial intelligence
    • data management
    • champion
    • startup
    Related Knowledge Center
    • Digital Health
    • Diagnostics
    Suggested For You
    Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles
    Mayo Clinic, Google Research AI Software Could Boost Brain Stim Devices Mayo Clinic, Google Research AI Software Could Boost Brain Stim Devices
    Why Patient Data Security is of Essential Importance in 2021 Why Patient Data Security is of Essential Importance in 2021
    Hyperfine Welcomes Dave Scott as President and CEO Hyperfine Welcomes Dave Scott as President and CEO
    First Clinical Use of SoundBite Medical First Clinical Use of SoundBite Medical's Active Wire Platform
    GE Healthcare, AWS Partner to Transform Care Delivery GE Healthcare, AWS Partner to Transform Care Delivery
    Five Tips to Protect IP While Working with a Freelancer Five Tips to Protect IP While Working with a Freelancer
    5 Guidelines for Productizing an Optically Based Medical Device 5 Guidelines for Productizing an Optically Based Medical Device
    Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy
    Medtech Medtech's Cross Border Venture Financing Deals Top $1B in Q4 2020
    Medical Device Cross Border Deal Activity in U.S. Rises in Q4 2020 Medical Device Cross Border Deal Activity in U.S. Rises in Q4 2020
    Cross Border Venture Financing Rose in Final Quarter of 2020 Cross Border Venture Financing Rose in Final Quarter of 2020
    Soundbite Medical Wins Health Canada Approval for PAD Treatment Soundbite Medical Wins Health Canada Approval for PAD Treatment
    January AI Raises $8.8 Million in New Funding January AI Raises $8.8 Million in New Funding
    Global Medical Device Venture Financing Deals Total $3.84 Billion in Q4 2020 Global Medical Device Venture Financing Deals Total $3.84 Billion in Q4 2020

    Related Breaking News

    • Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles

      Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles

      Neela Paykel is serving as general counsel and Tom Teisseyre assumes the chief product officer position.
      Business Wire 09.22.21

    • Neurological | Software & IT
      Mayo Clinic, Google Research AI Software Could Boost Brain Stim Devices

      Mayo Clinic, Google Research AI Software Could Boost Brain Stim Devices

      Algorithm may help understand which brain regions directly interact with one another.
      Mayo Clinic 09.07.21

    • Digital Health
      Why Patient Data Security is of Essential Importance in 2021

      Why Patient Data Security is of Essential Importance in 2021

      How to protect confidential patient information and comply with regulations such as HIPAA.
      Anton Zheliabin, Product manager, ComeBack Mobility 08.25.21


    • Hyperfine Welcomes Dave Scott as President and CEO

      Hyperfine Welcomes Dave Scott as President and CEO

      New leader worked for Apple, Google (Verb Surgical), and led the design team for Intuitive Surgical's visualization platform.
      Business Wire 08.23.21

    • First Clinical Use of SoundBite Medical

      First Clinical Use of SoundBite Medical's Active Wire Platform

      Doctors tout strong results with the company's Active Wire 0.014-inch platform in severely calcified peripheral lesions.
      Business Wire 08.13.21

    Loading, Please Wait..

    Breaking News
    • MPO's Most-Read Stories This Week—Dec. 9
    • Babson Diagnostics’ BetterWay Achieves Regulatory Milestone
    • WhiteSwell Successfully Treats Acute Decompensated Heart Failure in Study
    • Everly Health Releases At-Home Collection Kidney Health Test
    • Kenco Adds Two to its Life Sciences Division Team
    View Breaking News >
    CURRENT ISSUE

    November 2023

    • MPO's 2023 Medical Device Industry Year in Review
    • The Beat Goes On in the Cardiovascular Device Market
    • Medical Manufacturers Gain Support from 3D Printing
    • The Intelligent Tools Medical Device Manufacturers Already Own
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Women in Nutraceuticals Hires Executive Director Rebecca Takemoto
    FDA Issues Interim Response to Nammex’s Mushroom Labeling Petition
    MSM Linked to Improvements in Knee Pain
    Coatings World

    Latest Breaking News From Coatings World

    Weekly Recap: PPG, PPG Asian Paints, AkzoNobel Top This Week’s Stories
    Orion S.A. Has Four Carbon Black Plants Awarded ISCC PLUS
    Peninsula Polymers Acquires New Distribution Center in Indiana
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—Dec. 9
    Babson Diagnostics’ BetterWay Achieves Regulatory Milestone
    WhiteSwell Successfully Treats Acute Decompensated Heart Failure in Study
    Contract Pharma

    Latest Breaking News From Contract Pharma

    FDA Approves Bio-Thera's Biosimilar Referencing Roche’s Avastin
    Full-Life Technologies to Build GMP Radiopharmaceuticals Mfg. Facility
    Innovent Biologics, Synaffix Expand ADC Licensing Deal
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    COSRX’s Latest TikTok Campaign Accumulates 3.2B Views on TikTok
    Christian Louboutin Taps Morgane Martini as Global Makeup Artist
    Shiseido Forms New Venture Fund
    Happi

    Latest Breaking News From Happi

    Diya Beauty & Wellness Acquires WR Group's Retail Brands and North American Sales Division
    Pantone Color of the Year & A New CEO
    When It Comes to Bath and Body Rituals, Consumers Want The Works
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: Siegwerk, DIC, and Müller Martini Top This Week’s Stories
    Orion S.A. Now Has Four Carbon Black Plants Awarded ISCC PLUS
    BASF Commits to Scope 3.1 Emissions Targets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Analyzing the Russian label market, Carter boosts brands and more
    FLAG’s December Lunch & Learn to feature Omet
    UPM Raflatac releases neuromarketing study findings
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: New Dates for INDEX 26, Campen Announces Patent Pending Status for Airlaid Trays
    Ginni Strikes Deal to Sell Spinning, Knitting Operations
    Campen Machinery Announces Patent Pending Status for Airlaid Trays
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—Dec. 9
    Fujitsu, iSurgery Launch Bone Health Promotion Project in Japan
    Wenzel Spine Hires Dr. Robert Gordon as Executive Chairman
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: Schreiner MediPharm, GIANCE and PragmatIC Top This Week’s Stories
    Intel CEO Pat Gelsinger to Cover AI During CES 2024 Keynote
    Ciena Invests in US Manufacturing with Flex

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login